• Home
• Business Licensing
• Obtaining a Pharmaceutical Enterprise License in Georgia

Obtaining a Pharmaceutical Enterprise License in Georgia

Irakli

RegHub Georgia Specialist

Obtaining a pharmaceutical enterprise license in Georgia is a necessary step if you want to legally launch the production and circulation of medicinal products. It opens the door to the local market, gives access to export routes, and allows a company to operate inside a tightly regulated industry.

Securing authorization for pharmaceutical activity in Georgia is not a single action but a layered process built on interconnected legal mechanisms and regulatory requirements. The approval framework is shaped by a combination of mandatory control procedures and admission criteria. Entering the market requires several things at once: officially obtaining pharmaceutical enterprise status, receiving a separate permit for manufacturing medicines, and fully complying with strict quality standards. In practice, this means navigating the process of obtaining a pharmaceutical enterprise license in Georgia with attention to every regulatory detail, not just paperwork.

The legislation builds a licensing model for pharmaceutical businesses in Georgia where each component serves its own purpose. The enterprise status formally recognizes the market participant, the license grants the right to manufacture, and the standards confirm that everything meets established benchmarks of quality and safety.

What Is Considered a Georgian Pharmaceutical Enterprise

A pharmaceutical enterprise is a legal entity engaged in the production of medicinal products and their introduction into circulation within the jurisdiction. The law treats such a company as a participant in a regulated sector, which means it must meet specific requirements related to product quality, manufacturing conditions, and control at every stage of distribution.

To classify a business under this category, the nature of its activity matters. A pharmaceutical enterprise typically includes organizations that:

• manufacture medicinal products, including finished drugs as well as items at various stages of the production cycle;

• ensure the supply of produced goods to wholesale channels or other distribution networks;

• participate in the circulation of pharmaceutical products as both manufacturer and seller.

At the same time, simply engaging in trading operations without any production stage does not qualify a company for this status, even if it works directly with medicinal products.

Formalizing a Georgian Pharmaceutical Enterprise Permit: Regulatory Framework

Putting together a Georgian pharmaceutical enterprise permit is not built on a single rulebook. It’s a layered system where industry law, tax provisions, and general licensing legislation all intersect. Together, they shape what qualifies as a pharmaceutical business, outline how production is allowed, and define who controls the process at the state level.

The core legal anchor is the Law on Medicines and Pharmaceutical Activities. It follows a product through its entire journey — from early-stage development and manufacturing to distribution and final sale. A lot of weight is placed on monitoring how medicines are produced and whether quality standards are consistently met. That’s exactly where the process of securing a Georgian pharmaceutical enterprise permit becomes more than formal — it turns into a real compliance challenge.

On the administrative side, a separate act on licenses and permits steps in. It doesn’t dive into production specifics, but it explains how businesses interact with authorities when arranging pharmaceutical authorization in Georgia.

This framework sets out:

• the types of permits that can be issued;

• baseline expectations for applicants;

• how applications are submitted and reviewed;

• why a permit may be denied, paused, or revoked.

The technical side of running a pharmaceutical operation is handled through subordinate regulations. These include government resolutions on granting enterprise status, Ministry of Health orders covering facility standards and quality control, and technical rules tied to GMP and GDP principles. On top of that, sanitary and technological requirements apply to premises, equipment, and workflows — shaping the real conditions behind launching pharmaceutical operations in Georgia.

Which Authorities Are Involved in Licensing Pharmaceutical Manufacturing in Georgia

The system behind gaining approval for pharmaceutical production in Georgia is split between several state bodies. Each one plays its own role, and their responsibilities are clearly separated — no overlap, no confusion.

The Government of Georgia is responsible for granting pharmaceutical enterprise status. This step stands on its own and does not replace issuing a pharmaceutical manufacturing permit in Georgia. It’s more about formally recognizing a legal entity as part of the pharmaceutical sector, giving it the right to operate within this field.

The government’s powers include:

• making decisions on granting enterprise status;

• defining how this status is issued and terminated;

• setting the operating conditions for such entities.

Without this recognition, a company simply cannot be treated as a pharmaceutical manufacturer in the legal sense.

The actual process of handling pharmaceutical licensing in Georgia is assigned to a specialized agency. This body takes on the operational side of approvals and oversees how the sector functions in practice.

Its responsibilities include:

• granting permits for pharmaceutical production in Georgia;

• reviewing applications and verifying submitted documentation;

• assessing whether production facilities meet established standards;

• maintaining the official register of pharmaceutical operators;

• monitoring compliance with permit conditions and quality requirements.

In reality, this agency is where most of the licensing journey happens — from submission to final approval.

The Ministry of Health, which is in charge of the industry, has a distinct function. Instead of direct approvals, it emphasizes collaboration and regulation. The entire structure that businesses operate under is shaped by its work.

The ministry:

• develops state policy for the circulation of pharmaceutical products;

• drafts and approves subordinate legal acts;

• sets requirements for quality, safety, and production conditions;

• coordinates the work of the agency under its supervision.

So, the structure is quite straightforward in practice: the ministry defines the rules of the game, while the agency applies them when navigating pharmaceutical approval in Georgia and keeps everything under control afterward.

Obtaining a Pharmaceutical Enterprise License in Georgia: Requirements for Applicants

Gaining approval for pharmaceutical activity in Georgia is only possible when several conditions come together at once: the right legal structure, a clearly defined type of operations, and real technical readiness of the facility. The law doesn’t treat all market players equally — it separates them by activity and sets different entry thresholds for each.

Legal Structure

Only a legal entity registered in Georgia can apply for a pharmaceutical enterprise license in Georgia. In practice, businesses usually choose an LLC (similar to an LLC) or a JSC (joint-stock company). There are no strict limits on foreign ownership — non-residents can fully own the company. Still, the actual operations must run through a Georgian entity listed in the national register. That local presence is not optional — it’s the foundation of setting up a pharmaceutical business in Georgia.

Type of Planned Activity

The requirements for securing permission to manufacture pharmaceutical products in Georgia depend directly on what the company plans to do.

The law distinguishes several areas of activity:

• manufacturing activity;

• wholesale supply of pharmaceutical products;

• retail sales through pharmacies;

• other operations related to the circulation of medicines.

Manufacturing comes with the toughest entry conditions. It involves a full inspection of the site and strict control over technological processes. Wholesale operations add another layer — compliance with GDP standards, which govern storage and transportation. Pharmacy activity stands apart: it doesn’t require a production base, but it follows its own regulatory path.

Production Infrastructure in Place

To launch pharmaceutical manufacturing in Georgia, having a ready-to-use facility is not just expected — it’s mandatory. The site must exist in reality and be fully prepared for inspection by the competent authority.

What gets evaluated:

• premises divided into zones according to production stages;

• equipment suitable for the specific type of products;

• engineering systems, including ventilation, water supply, and environmental control;

• internal documentation covering production and quality management;

• qualifications of staff involved in the technological process.

If this infrastructure isn’t in place, moving forward with licensing simply isn’t an option.

Compliance with GMP and GDP Standards

For manufacturers, meeting GMP standards is non-negotiable. It covers:

• production conditions;

• quality control procedures;

• documentation systems;

• product traceability.

Operating without a national GMP certificate leads to penalties.

If the business includes wholesale distribution, compliance with GDP standards becomes an additional requirement. Ignoring it brings the same result — fines and regulatory pressure.

Questions about pharmaceutical licensing in Georgia?

We advise on the requirements and procedure for obtaining a pharmaceutical enterprise license in Georgia. Our team supports documentation, compliance review, and interaction with regulatory authorities throughout the process.

Request a consultation

Dossier for Obtaining a Pharmaceutical Enterprise License in Georgia

The package required for obtaining a pharmaceutical activity license in Georgia is built in several layers. Each section confirms a different piece of the puzzle — legal standing, availability of a facility, technical readiness, and compliance with quality standards. Nothing here is random; every document plays its role in preparing a pharmaceutical licensing dossier in Georgia.

Application and Forms from the Authorized Body

The process of issuing a pharmaceutical manufacturing license in Georgia begins with submitting a formal request in the required format. This part includes:

• an application specifying the type of activity;

• attachments listing all submitted materials;

• details about the production site and technological processes;

• additional forms required by the authorized agency.

The full package is submitted through official channels defined by the regulator. Once filed, it becomes the starting point for the evaluation procedure.

Corporate Documents of the Applicant

This section confirms the company’s legal capacity and internal structure. It typically includes:

• founding documents of the legal entity;

• an extract from the state register confirming registration;

• details about the director and other authorized representatives;

• information on the legal address and actual place of operations;

• data on beneficial owners.

These materials help identify the applicant and verify eligibility for entering the pharmaceutical sector in Georgia under the required legal conditions.

Documents on the Facility and Production Base

A separate block focuses on the physical site and its readiness. To move forward with securing pharmaceutical business authorization in Georgia, the company must provide:

• proof of ownership or lease of the premises;

• floor plans and layout drawings showing functional zoning;

• a description of production, storage, and quality control areas;

• details of equipment used in the technological process;

• information on engineering systems, including ventilation, water supply, and environmental control.

These documents allow regulators to assess whether the site meets established standards.

Technical and Pharmaceutical Documentation

This part reveals how the applicant has structured production and quality control in practice. It includes:

• descriptions of technological operations at each stage of production;

• the quality assurance and internal control system;

• standard operating procedures (SOPs);

• validation documents for processes and equipment;

• information about personnel responsible for production and quality control, including qualifications and role distribution.

Together, this block demonstrates the company’s real ability to manufacture products in line with regulatory expectations and maintain consistent quality across every batch.

How to Arrange a Georgian Pharmaceutical Enterprise Permit

The path to licensing a pharmaceutical business in Georgia unfolds step by step. It starts with establishing the company, moves through securing production approval, and ends with proving compliance with strict quality standards — all parts of setting up pharmaceutical operations in Georgia working together.

1. Registering a legal entity in Georgia.The company is registered through the National Agency of Public Registry based on submitted incorporation documents and director details. This can be done via the Public Service Hall or an online portal. A state fee is paid at the filing stage, and once the application is reviewed, an official registry extract is issued.

2. Defining the business model.At this point, the type of activity is fixed. Whether the company plans manufacturing, distribution, or retail determines if it needs securing a pharmaceutical production permit in Georgia and obtaining GMP or GDP certificates.

3. Preparing the production site and quality system.Facilities are organized with clear zoning, equipment is installed, and the technological flow is structured. Internal quality control procedures are introduced, including documentation for production stages and product traceability.

4. Submitting an application for pharmaceutical enterprise status.The request is filed on behalf of the registered company with the authorized state body, along with corporate and industry-specific materials. The government makes the final decision based on the submitted dossier.

5. Applying for a pharmaceutical manufacturing permit in Georgia.The application is sent to a specialized agency within the Ministry of Health system. It includes details on the facility, equipment, and production processes. The authority reviews the data and decides on granting pharmaceutical manufacturing approval in Georgia.

6. Passing inspection and obtaining a GMP certificate.The authorized body inspects the production site for compliance with Good Manufacturing Practice standards. After a successful check, a national certificate is issued, confirming that quality requirements are met.

7. Obtaining a GDP certificate for wholesale operations.If the business involves distribution, a separate application is submitted for Good Distribution Practice certification. Storage and transportation conditions must be confirmed, and warehouse and logistics systems are inspected.

Once the company holds its status, permit, and required certificates, it can begin operating. From that point on, everything must align with the issued documents, product quality rules, and circulation standards. Any deviation brings administrative consequences.

Entering the Pharmaceutical Sector in Georgia

Entering the pharmaceutical sector in Georgia means more than just registering a business. It requires setting up a local company, clearly separating enterprise status, securing a production permit, and obtaining mandatory quality certificates. Miss a step or mix things up — and the result is either refusal or penalties that can hit even after operations begin. This is where entering the pharmaceutical sector in Georgia becomes a process that rewards precision, not shortcuts.

Professional support when handling pharmaceutical licensing in Georgia helps keep everything aligned from the start. It allows you to separate different approval tracks without confusion, choose the right business model, prepare the production site in advance for inspection, and build a complete dossier without gaps. In practice, this means faster review timelines and fewer risks of resubmissions, delays, or fines down the road.